http://www.theindependent-bd.com/details.php?nid=126445
Beximco Pharma exports Oseltamivir capsules to Latin and Central America
Economic Reporter
Beximco Pharmaceuticals Ltd. (BPL) yesterday announced that it has commenced supplying Oseltamivir capsules, Oseflu (BPL’s generic version of Tamiflu), to Latin and Central American countries, the regions most affected by the recent H1N1 swine flu (influenza A) outbreak.
The World Health Organization (WHO) estimates that 39 countries have officially reported 8,480 cases of influenza A (H1N1) infection, (WHO update 31, 17 May 2009). H1N1 appears to be more contagious than seasonal influenza and the new virus causing swine flu has been found to respond positively to Oseltamivir treatment.
Nazmul Hassan, Managing Director of Beximco Pharmaceuticals, commented: “BPL is the first company from Bangladesh to help combat the swine flu outbreak in Latin and Central American countries. The company has already supplied Oseflu stocks to the Ministry of Health in Chile and Belize, as well as to high profile Government and non-Government agencies. We look forward to helping to combat this virus which has already affected many people across the world.”
Beximco Pharmaceuticals introduced Oseltamivir capsule Oseflu in 2006 for the prevention and treatment of influenza including swine and bird flu. In the same year BPL supplied Oseflu to the Bangladesh and Myanmar governments for stockpiling to combat the Bird flu pandemic. The company has increased its Oseflu stock to ensure further supply into other countries in the near future.
